Oxford, United Kingdom

Matthew Guy Cottingham

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 53(Granted Patents)


Location History:

  • Reading, GB (2007)
  • Headington, GB (2016 - 2018)
  • Oxford, GB (2015 - 2024)
  • Oxfordshire, GB (2022 - 2024)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Matthew Guy Cottingham

Introduction

Matthew Guy Cottingham is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of medicine through his innovative work in recombinant adenoviral vectors. With a total of 10 patents to his name, Cottingham's inventions are paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents, Cottingham has developed a recombinant adenoviral vector that provides immunogenic compositions and their uses in medicine. This invention specifically includes an adenoviral vector that comprises the genome of an adenovirus other than AdHu5 and AdY25. The genome has been modified to lack the native E4 locus of the adenovirus while incorporating heterologous E4Orf1, E4Orf2, and E4Orf3 coding regions from AdY25. This innovative approach enhances the potential applications of adenoviral vectors in therapeutic settings.

Career Highlights

Cottingham has worked with notable organizations such as Oxford University Innovation Limited and Isis Innovation Limited. His career is marked by a commitment to advancing medical technology and improving patient outcomes through innovative research and development.

Collaborations

Throughout his career, Cottingham has collaborated with esteemed colleagues, including Sarah C. Gilbert and Adrian Vivian Sinton Hill. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking inventions

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…